Comments
Loading...

Replimune Group Analyst Ratings

REPLNASDAQ
Logo brought to you by Benzinga Data
Consensus Rating1
Outperform
Highest Price Target1
$60.00
Lowest Price Target1
$17.00
Consensus Price Target1
$30.92

Replimune Group Analyst Ratings and Price Targets | NASDAQ:REPL | Benzinga

Replimune Group Inc has a consensus price target of $30.92 based on the ratings of 13 analysts. The high is $60 issued by EF Hutton on June 7, 2023. The low is $17 issued by Roth MKM on August 27, 2024. The 3 most-recent analyst ratings were released by Piper Sandler, JP Morgan, and HC Wainwright & Co. on June 2, 2025, February 26, 2025, and February 13, 2025, respectively. With an average price target of $20.67 between Piper Sandler, JP Morgan, and HC Wainwright & Co., there's an implied 123.91% upside for Replimune Group Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Jan
2
Feb
2
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Piper Sandler
JP Morgan
HC Wainwright & Co.
BMO Capital
Jefferies

1calculated from analyst ratings

Analyst Ratings for Replimune Group

Buy NowGet Alert
06/20/2025Buy NowCantor Fitzgerald
Li Watsek42%
Initiates → OverweightGet Alert
06/02/2025Buy Now138.35%Piper Sandler
Allison Bratzel71%
$14 → $22MaintainsOverweightGet Alert
02/26/2025Buy Now95.02%JP Morgan
Anupam Rama59%
$16 → $18MaintainsOverweightGet Alert
02/13/2025Buy Now138.35%HC Wainwright & Co.
Robert Burns45%
$21 → $22MaintainsBuyGet Alert
01/22/2025Buy Now192.52%BMO Capital
Evan David Seigerman50%
$18 → $27MaintainsOutperformGet Alert
01/22/2025Buy Now127.52%HC Wainwright & Co.
Robert Burns45%
$17 → $21MaintainsBuyGet Alert
12/04/2024Buy Now105.85%Jefferies
Roger Song36%
$16 → $19MaintainsBuyGet Alert
11/22/2024Buy Now95.02%BMO Capital
Evan David Seigerman50%
$14 → $18MaintainsOutperformGet Alert
11/22/2024Buy Now84.18%HC Wainwright & Co.
Robert Burns45%
$17 → $17ReiteratesBuy → BuyGet Alert
11/12/2024Buy Now84.18%HC Wainwright & Co.
Robert Burns45%
$17 → $17ReiteratesBuy → BuyGet Alert
09/24/2024Buy Now84.18%JP Morgan
Anupam Rama59%
$14 → $17MaintainsOverweightGet Alert
09/16/2024Buy Now84.18%HC Wainwright & Co.
Robert Burns45%
$17 → $17ReiteratesBuy → BuyGet Alert
09/10/2024Buy Now84.18%HC Wainwright & Co.
Robert Burns45%
$17 → $17ReiteratesBuy → BuyGet Alert
08/27/2024Buy Now84.18%Roth MKM
Benjamin Paluch35%
→ $17Initiates → BuyGet Alert
08/13/2024Buy Now51.68%JP Morgan
Anupam Rama59%
$17 → $14MaintainsOverweightGet Alert
06/07/2024Buy Now84.18%Barclays
Peter Lawson42%
$13 → $17MaintainsOverweightGet Alert
06/07/2024Buy Now84.18%HC Wainwright & Co.
Robert Burns45%
$12 → $17MaintainsBuyGet Alert
12/06/2023Buy Now40.85%Barclays
Peter Lawson42%
$50 → $13MaintainsOverweightGet Alert
11/13/2023Buy Now420.04%HC Wainwright & Co.
Robert Burns45%
$50 → $48MaintainsBuyGet Alert
11/08/2023Buy Now463.38%Wedbush
Robert Driscoll44%
→ $52ReiteratesOutperform → OutperformGet Alert
08/07/2023Buy Now441.71%HC Wainwright & Co.
Robert Burns45%
$51 → $50MaintainsBuyGet Alert
08/01/2023Buy Now452.55%HC Wainwright & Co.
Robert Burns45%
→ $51ReiteratesBuy → BuyGet Alert
06/15/2023Buy Now441.71%JP Morgan
Anupam Rama59%
$38 → $50MaintainsOverweightGet Alert
06/08/2023Buy Now452.55%HC Wainwright & Co.
Robert Burns45%
→ $51ReiteratesBuy → BuyGet Alert
06/07/2023Buy Now463.38%Wedbush
Robert Driscoll44%
→ $52ReiteratesOutperform → OutperformGet Alert
06/07/2023Buy Now550.05%EF Hutton
Tony Butler42%
→ $60ReiteratesBuy → BuyGet Alert
06/05/2023Buy Now452.55%HC Wainwright & Co.
Robert Burns45%
$50 → $51MaintainsBuyGet Alert
06/05/2023Buy Now550.05%EF Hutton
Tony Butler42%
→ $60ReiteratesBuy → BuyGet Alert
05/26/2023Buy Now550.05%EF Hutton
Tony Butler42%
→ $60ReiteratesBuy → BuyGet Alert
05/22/2023Buy Now463.38%Wedbush
Robert Driscoll44%
→ $52ReiteratesOutperform → OutperformGet Alert
04/17/2023Buy Now376.71%Piper Sandler
Allison Bratzel71%
→ $44Assumes → OverweightGet Alert
02/10/2023Buy Now441.71%HC Wainwright & Co.
Robert Burns45%
$48 → $50Reiterates → BuyGet Alert
01/05/2023Buy Now550.05%EF Hutton
Tony Butler42%
→ $60Initiates → BuyGet Alert
12/12/2022Buy Now658.4%BMO Capital
Evan David Seigerman50%
$40 → $70MaintainsOutperformGet Alert
12/07/2022Buy Now268.36%SVB Leerink
Jonathan Chang38%
$30 → $34MaintainsOutperformGet Alert
11/04/2022Buy Now420.04%HC Wainwright & Co.
Robert Burns45%
$60 → $48MaintainsBuyGet Alert
10/14/2022Buy Now333.37%BMO Capital
Evan Seigerman63%
$30 → $40MaintainsOutperformGet Alert
10/03/2022Buy Now225.03%SVB Leerink
Jonathan Chang38%
$37 → $30MaintainsOutperformGet Alert
08/16/2022Buy Now365.87%Piper Sandler
Do Kim54%
$44 → $43MaintainsOverweightGet Alert
08/05/2022Buy Now300.87%SVB Leerink
Jonathan Chang38%
$48 → $37MaintainsOutperformGet Alert

FAQ

Q

What is the target price for Replimune Group (REPL) stock?

A

The latest price target for Replimune Group (NASDAQ:REPL) was reported by Cantor Fitzgerald on June 20, 2025. The analyst firm set a price target for $0.00 expecting REPL to fall to within 12 months (a possible -100.00% downside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Replimune Group (REPL)?

A

The latest analyst rating for Replimune Group (NASDAQ:REPL) was provided by Cantor Fitzgerald, and Replimune Group initiated their overweight rating.

Q

When was the last upgrade for Replimune Group (REPL)?

A

There is no last upgrade for Replimune Group

Q

When was the last downgrade for Replimune Group (REPL)?

A

There is no last downgrade for Replimune Group.

Q

When is the next analyst rating going to be posted or updated for Replimune Group (REPL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Replimune Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Replimune Group was filed on June 20, 2025 so you should expect the next rating to be made available sometime around June 20, 2026.

Q

Is the Analyst Rating Replimune Group (REPL) correct?

A

While ratings are subjective and will change, the latest Replimune Group (REPL) rating was a initiated with a price target of $0.00 to $0.00. The current price Replimune Group (REPL) is trading at is $9.23, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch